Nuveen’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.9M Sell
443,484
-128,619
-22% -$4.63M ﹤0.01% 1298
2026
Q1
$18.4M Sell
572,103
-7,136
-1% -$262K 0.01% 1182
2025
Q4
$22.2M Buy
579,239
+428,672
+285% +$9.4M 0.01% 1085
2025
Q3
$2.07M Sell
150,567
-99,485
-40% -$1.17M ﹤0.01% 2282
2025
Q2
$3.23M Buy
250,052
+79,415
+47% +$826K ﹤0.01% 2085
2025
Q1
$1.92M Buy
170,637
+69,400
+69% +$911K ﹤0.01% 2352
2024
Q4
$1.33M Sell
101,237
-239,829
-70% -$6.15M ﹤0.01% 2573
2024
Q3
$13.6M Buy
341,066
+214,095
+169% +$7.78M ﹤0.01% 1426
2024
Q2
$3.75M Buy
+126,971
New +$3.46M ﹤0.01% 2089

Other funds holding PACS

Nuveen's PACS Position: Q2 2026 in Review

Nuveen reduced its PACS Group (PACS) stake by 22% in Q2 2026, selling an estimated $4.63M and leaving 443,484 shares worth $18.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1298.

Nuveen first reported a position in PACS in Q2 2024 and has held it in 9 quarters since. The position peaked at $22.2M in Q4 2025. 240 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Nuveen held 443,484 shares of PACS Group worth $18.9M as of Q2 2026.
  • Nuveen sold 128,619 PACS Group shares in Q2 2026, an estimated $4.63M.
  • PACS Group made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1298 holding.
  • Nuveen first reported a position in PACS Group in Q2 2024 and has held it in 9 quarters since.
  • Nuveen's PACS Group position peaked at $22.2M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.